Speakers

Energy Kristina Hansen

Energy Kristina Hansen

MilCor Consulting

Tim Ohlrich

Tim Ohlrich

gempex

Cecilie Hejlskov

Cecilie Hejlskov

Ferring

Wolfgang Schmitt

Wolfgang Schmitt

CONCEPT HEIDELBERG

 


Target Group

  • Personnel involved in failure investigations and root cause analysis (RCA)
  • Quality Assurance professionals responsible for deviation management and CAPA
  • Anyone contributing to or reviewing event, deviation, or CAPA management within the organisation

Objectives

  • Understand fundamental principles of effective failure Investigation
  • Learn to distinguish true root causes from causes and symptoms such as “human error”
  • Explore structured tools and methodologies
Background
Things will go wrong from time to time. In the world of pharmaceuticals, we need to ensure that we have robust processes and procedures in place to deal with such situations. When an unplanned event arises, it must be handled accordingly.
 
EudraLex Vol. 4, EU-GMP Guidelines, Chapter 1 (Pharmaceutical Quality System):
1.4 (xiv): “An appropriate level of root cause analysis should be applied during the investigation of deviations, suspected product defects and other problems.”
 
In any case a sound failure investigation is the key to identify appropriate actions and CAPAs. Here, understanding how to handle both human error- and non-human error-based non-conformances is crucial.
 
EudraLex Vol. 4, EU-GMP Guidelines, Chapter 1 (Pharmaceutical Quality System):
1.8: […] “The basic requirements of GMP are that: (vii) Any significant deviations are fully recorded, investigated with the objective of determining the root cause and appropriate corrective and preventive action implemented”
 
Root cause analysis (RCA) is a process that attempts to identify the exact cause of a problem, such as a deviation. Only by identifying the exact underlying fault it is possible to take the right action to solve the problem and prevent it from occurring again.


Programme

Kick-off: When it’s human

  • Expectations on Humans
  • Why human error could not be a root cause
  • Blame culture vs. Root Cause
  • Error Culture

Excerpt from FDA Warning Letter
“…the investigation failed to establish a root cause and your quality unit failed to ensure the implementation of adequate corrective actions to prevent future recurrence.”

Presentation and Workshop:
Using 5 Whys and Ishikawa

  • Short Introduction of the methods
  • Strengths and weaknesses of each method
  • Typical mistakes in application
  • Workshop: Real life examples and experiences

Interactive Session: Comparative Analysis

  • Identifying and documenting errors with worksheets
  • The need for a systematic approach
  • The key for success: comparison of occurred deviations with available facts

Bow-Tie Risk Management and Problem Solving Analysis

  • Controls, connection and causality
  • Risk velocity
  • Preventive, detective and corrective controls
  • The link to Fault Tree Analysis and Event Tree Analysis

Interactive Session: A3 Methodology

  • What is a problem?
  • The causes investigation; point of cause, direct cause and root cause
  • The 8-steps, structure and methodology
  • Deep Dive: Point of cause analysis
  • Solving a murder case

Human Error Related Deviations

  • The What
    - Top 10 Categories: FDA Warning Letters (2021-2022)
    - The commonality
    - Undesirable behaviour…what is it?
  • The How
    - The KAP model
    - Factor in the social element
  • The Recurrence
    - Human Error is NEVER a root cause
    - Blame it on the culture
Behavioural Root Cause Analysis (bRCA) for Human Error Related Deviations (HErD)
  • Behavioural Root Cause Analysis tool (3B Method)
  • Theory behind 3B method
    - Informative construct (brain)
  • - Motivational construct (beating heart)
    - Perceived barriers construct (brick)
  • Utilize the solution
    - Sort the HErD: 3B Method
    - Practice in groups

RCA Completion

  • How to document a Root Cause Analysis
  • How to define the right actions based on the outcome

Deviation Management and CAPA
Principles and all relevant aspects to implement, improve and/ or work with a Deviation Management and CAPA System are topic of ECA’s Deviation Management and CAPA training course. For more information see www.gmp-compliance.org/ or send an e-mail to w.schmitt@concept-heidelberg.de.


Further Information

Venue
Radisson Blu Scandinavia Hotel
Amager Boulevard 70
2300 Copenhagen
Denmark
+45 33 96 50 00
guest.copenhagen@radissonblu.com

Accommodation
CONCEPT HEIDELBERG has reserved a limited number of rooms in the conference hotel. You will receive a room reservation form when you have registered for the course. Reservation should be made directly with the hotel. Early reservation is recommended.

Social Event
On 02 September you are cordially invited to a social event (including Dinner). This is an excellent opportunity to share your experiences with colleagues from other companies in a relaxed atmosphere.

Fees (per delegate plus VAT)
ECA Members EUR 1,890.-
APIC Members EUR 1,990.- (does not include ECA Membership)
Non-ECA Members EUR 2,090.-
EU GMP Inspectorates EUR 1,045.-
The conference fee is payable in advance after receipt of invoice and includes lunch on both days, dinner on day 1 and all refreshments. VAT is reclaimable.

Presentations/Certificate
The presentations for this event will be available for you to download and print before and after the event. Please note that no printed materials will be handed out on site and that there will not be any opportunity to print the presentations on site.After the event, you will automatically receive your certificate of participation.
 
Conference language
The official conference language will be English.
 
Contacts
Questions regarding Content:
Mr Wolfgang Schmitt, +49 6221 84 44-39, w.schmitt@concept-heidelberg.de
Questions regarding organisation:
Ms Isabell Helm, +49 6221 84 44-49, helm@concept-heidelberg.de


Date & Time

Wed, 02 September 2026, 09:00–17:45
Thu, 03 September 2026, 08:30–15:30

Costs

ECA-Member*: € 1890,-
Non ECA Member*: € 2090,-
EU/GMP Inspectorates*: € 1045,-
APIC Member Discount*: € 1990,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

icon
Recording/ Additional dates on-site
not available
Recording/ Additional dates on-site
not available
stop

This course is part of the GMP Certification Programme "ECA Certified Quality Assurance Manager"

Go back

Testimonials about our courses and conferences

"Great material and speakers" and "Great speakers a lot of experience and sharing"

Felipe Gonzalez, Mucos Emulsionsgesellschaft mbH
Live Online Training - Granulation & Tableting, September 2024

“I found the course eye opening and very well organized.”

Jozsef Maklary, Veolia Industries Austria GmbH
The GMP-Compliance Manager, October 2025

"I am so grateful for having attended this course. Great job from all, and very profitable. Thanks!”

Alba Aranda Cuesta, Kern Pharma
KPIs and Quality Metrics, Berlin, Germany, April 2025

"The lectures were very informative, interesting and entertaining."

Albert Godoy Hernández, Company synaffix
Live Online Training - GMP Auditor Practice, October 2024

"Really useful training which I will use in my daily work."

Regina Mommaerts, Galapagos NV
Live Online Training - GMP Auditor Practice, October 2024

"Wonderful format of the sessions: Good range of participations and experience in the team. Would love to attend another one soon."

Roopasi Mathi, Wacker Biotech B.V.
Live Online Training - GMP Auditor Practice, October 2024

"Very good balance between general and detailed information"

Dr Ralf Albrecht, Tillotts Pharma AG
Live Online Training - Granulation & Tableting
September 2024

"Nice presentations: easy understanding, quite visual"

Susana Manrique, Boehringer Ingelheim España, S.A,
Live Online Training - Granulation & Tableting, September 2024

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Both, organizers and lecturers were very friendly, open for discussions and extremely constructive. The course was a valuable experience for me.”

Maria Dimitrova, NKN Law Firm
Pharmaceutical Contracts: GMP and Legal Compliance, March 2025